InsidersTradesSigma
Explore the detailed record of transactions filed by Hoekman John, Directeur Scientifique. Director active across 1 companies, notably Impel Neuropharma INC. In total, 4 disclosures have been logged. The latest transaction was filed on 22 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
John Hoekman is the Chief Scientific Officer at IMPEL NEUROPHARMA INC. He is responsible for leading research and development initiatives. Hoekman plays a crucial role in innovation and the development of new products.